scholarly journals The quality of artificial intelligence algorithms for identifying manifestations of multiple sclerosis on magnetic resonance imaging (systematic review)

2021 ◽  
Vol 15 (4) ◽  
pp. 54-65
Author(s):  
Galina N. Chernyaeva ◽  
Sergey P. Morozov ◽  
Anton V. Vladzimirskyy

A systematic review was undertaken to summarize the data regarding accuracy and effectiveness of artificial intelligence algorithms for identifying MRI manifestations of multiple sclerosis. The review included 39 papers, whose authors put forth a multitude of corresponding algorithms and mathematical models. However, quality assessment of these developments was limited by retrospective testing on repeat data sets. Clinical test results were almost entirely absent, and there were no prospective independent studies of accuracy and applicability. The relatively high values obtained for the main measures (similarity, sensitivity and specificity coefficients, which were 7585%) were offset by the methodological errors when creating the baseline data sets, and lack of validation using independent data. Due to small sample sizes and methodological errors when measuring the result accuracy, most of the studies did not meet the criteria for evidence-based research. Studies with the highest methodological quality had algorithms that achieved a sensitivity of 51.677.0%, with a SrensenDice coefficient of 53.556.0%. These numbers are not high, but they indicate that automatic identification of multiple sclerosis manifestations on magnetic resonance imaging may be achievable. Further development of computer-aided analysis requires the creation of clinical use scenarios and testing methodology, and prospective clinical testing.

2020 ◽  
Vol 28 ◽  
pp. 102371
Author(s):  
Benjamin V. Ineichen ◽  
Pascal Sati ◽  
Tobias Granberg ◽  
Martina Absinta ◽  
Nathanael J. Lee ◽  
...  

2021 ◽  
Vol 1 (4) ◽  
pp. 416-428
Author(s):  
Vijay Anant Athavale ◽  

Gadolinium (Gd) is a based contrast agent is used for Magnetic Resonance Imaging (MRI). In India, gadobutrolhas been is approved for MRI of the Central Nervous System (CNS), liver, kidneys, and breast. It has been noted in several studies that the accumulation of gadolinium occurs in different structures in the brain. Patients with Multiple Sclerosis (MS) are regularly followed up with MRI scans and MRI with contrast enhancement is the most common method of distinguishing new-onset pathological changes. Developments in technology and methods in artificial intelligence have shown that there is reason to map out the X-ray technician’s work with examinations and medicines administered to patients may be altered to prevent the accumulation of gadolinium.


BMJ ◽  
2006 ◽  
Vol 332 (7546) ◽  
pp. 875-884 ◽  
Author(s):  
Penny Whiting ◽  
Roger Harbord ◽  
Caroline Main ◽  
Jonathan J Deeks ◽  
Graziella Filippini ◽  
...  

2006 ◽  
Vol 31 (4) ◽  
pp. 319-319
Author(s):  
Penny Whiting ◽  
Roger Harbord ◽  
Caroline Main ◽  
Jonathan J Deeks ◽  
Graziella Filippini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document